News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Agilent Technologies Inc. (A) and Applied Proteomics, Inc. Will Collaborate to Maximize Capabilities of Highly Multiplexed Protein Assays


3/7/2013 10:26:56 AM

SANTA CLARA, Calif. & SAN DIEGO--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) and Applied Proteomics Inc. today agreed to collaborate on highly multiplexed protein assays and workflow solutions for multiple reaction monitoring through mass spectrometry. Proteins perform many important cellular functions, are the targets of most drugs and therapies, and are often used as biomarkers for detecting and monitoring disease. Applied Proteomics will leverage Agilent 6490 Triple Quadrupole MS/MS, 1290 Infinity LC, RapidFire 360 MS system and Bravo liquid-handling technologies to optimize the throughput of highly multiplexed proteomic assays. Multiple reaction monitoring, a highly specific and sensitive mass-spectrometry technique, can detect and quantify analytes from plasma, serum and other biological samples. A multiplex assay can simultaneously measure multiple analytes, such as proteins, peptides, metabolites and lipids.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES